Grandfield & Dodd, LLC Abbott Laboratories Transaction History

Grandfield & Dodd, LLC

  • $1.5 Billion
  • Q1 2024

A detailed history of Grandfield & Dodd, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Grandfield & Dodd, LLC holds 14,615 shares of ABT stock, worth $1.49 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
14,615
Previous 14,615 -0.0%
Holding current value
$1.49 Million
Previous $1.61 Million 3.3%
% of portfolio
0.11%
Previous 0.12%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 31, 2024
SELL
$90.19 - $110.4 $3,427 - $4,195
-38 Reduced 0.26%
14,615 $1.61 Million
Q3 2023

Oct 25, 2023
SELL
$95.53 - $114.62 $13,565 - $16,276
-142 Reduced 0.96%
14,653 $1.42 Million
Q2 2023

Aug 07, 2023
SELL
$100.78 - $112.29 $31,443 - $35,034
-312 Reduced 2.07%
14,795 $1.61 Million
Q1 2023

Apr 28, 2023
BUY
$96.86 - $114.01 $83,009 - $97,706
857 Added 6.01%
15,107 $1.53 Million
Q4 2022

Jan 20, 2023
SELL
$95.06 - $111.52 $2,661 - $3,122
-28 Reduced 0.2%
14,250 $0
Q2 2022

Aug 01, 2022
SELL
$102.07 - $123.37 $105,438 - $127,441
-1,033 Reduced 6.75%
14,278 $1.55 Million
Q1 2022

Apr 19, 2022
SELL
$114.02 - $139.04 $34,206 - $41,712
-300 Reduced 1.92%
15,311 $1.81 Million
Q4 2021

Feb 08, 2022
SELL
$115.53 - $141.46 $19,986 - $24,472
-173 Reduced 1.1%
15,611 $2.2 Million
Q2 2021

Jul 28, 2021
SELL
$105.79 - $124.53 $73,629 - $86,672
-696 Reduced 4.22%
15,784 $1.83 Million
Q1 2021

Apr 22, 2021
SELL
$108.84 - $128.23 $2,721 - $3,205
-25 Reduced 0.15%
16,480 $1.98 Million
Q3 2020

Nov 03, 2020
SELL
$91.64 - $111.29 $15,670 - $19,030
-171 Reduced 1.03%
16,505 $1.8 Million
Q2 2020

Jul 24, 2020
SELL
$76.57 - $98.0 $6,125 - $7,840
-80 Reduced 0.48%
16,676 $1.52 Million
Q1 2020

May 14, 2020
SELL
$62.82 - $91.86 $12,312 - $18,004
-196 Reduced 1.16%
16,756 $1.32 Million
Q4 2018

Feb 12, 2019
SELL
$65.56 - $74.27 $18,422 - $20,869
-281 Reduced 1.63%
16,952 $1.23 Million
Q3 2018

Nov 02, 2018
SELL
$60.81 - $73.36 $12,162 - $14,672
-200 Reduced 1.15%
17,233 $1.26 Million
Q2 2018

Jul 27, 2018
SELL
$57.57 - $63.54 $23,776 - $26,242
-413 Reduced 2.31%
17,433 $1.06 Million
Q1 2018

May 04, 2018
SELL
$56.27 - $63.62 $81,535 - $92,185
-1,449 Reduced 7.51%
17,846 $1.07 Million
Q4 2017

Feb 06, 2018
SELL
$53.68 - $57.47 $124,108 - $132,870
-2,312 Reduced 10.7%
19,295 $1.1 Million
Q3 2017

Nov 03, 2017
BUY
$48.06 - $53.64 $1.04 Million - $1.16 Million
21,607
21,607 $1.15 Million

Others Institutions Holding ABT

# of Institutions
3,118
Shares Held
1.29B
Call Options Held
8.43M
Put Options Held
8.19M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $179B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Grandfield & Dodd, LLC Portfolio

Follow Grandfield & Dodd, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Grandfield & Dodd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Grandfield & Dodd, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email